HomeBUSINESS
BUSINESS

Hisamitsu Sees Lower Ethical Drug Sales in March-August
(Oct.11.2017)

Japanese patch drug powerhouse Hisamitsu Pharmaceutical saw its first-half group sales edge down 1.3% to 73,463 million yen as it suffered revenue declines from ethical drug portfolios due to the lingering impact from last year’s drug price revision and generic erosions ...
(LOG IN FOR FULL STORY)

News Calendar